Crenezumab (Anti-Amyloid Beta)

Crenezumab (Anti-Amyloid Beta) is a fully humanized  immunoglobulin (Ig) G4 monoclonal antibody that targets amyloid beta (Abeta) with potential for use in Alzheimer's disease research. MW: 143.58 kD.

• Supplier: Selleck Chemicals
• Product #: A2764
• Sku #: A2764-1mg*25